Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood levels, potentially offering more significant outcomes for individuals with diabetes. Further research is underway to fully evaluate the long-term